GlaxoSmithKline Pharmaceuticals Limited (BOM: 500660)
India
· Delayed Price · Currency is INR 1,976.25
-5.10 (-0.26%)
At close: Jan 31, 2025
GlaxoSmithKline Pharmaceuticals Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jan '25 Jan 30, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Market Capitalization | 334,789 | 329,173 | 224,319 | 281,714 | 244,012 | 210,953 | Upgrade
|
| Market Cap Growth | 78.36% | 46.74% | -20.37% | 15.45% | 15.67% | -4.20% | Upgrade
|
| Enterprise Value | 313,828 | 313,334 | 211,499 | 270,099 | 237,483 | 201,694 | Upgrade
|
| Last Close Price | 1976.25 | 1910.37 | 1272.88 | 1505.45 | 1279.15 | 1077.26 | Upgrade
|
| PE Ratio | 49.60 | 55.80 | 36.73 | 16.62 | 68.13 | 226.33 | Upgrade
|
| Forward PE | 36.46 | 44.16 | 35.58 | 42.30 | 40.93 | 39.19 | Upgrade
|
| PS Ratio | 9.40 | 9.53 | 6.90 | 8.59 | 8.34 | 6.54 | Upgrade
|
| PB Ratio | 20.34 | 18.52 | 12.88 | 10.58 | 16.51 | 11.59 | Upgrade
|
| P/TBV Ratio | 28.21 | 18.77 | 13.14 | 10.72 | 17.01 | 11.91 | Upgrade
|
| P/FCF Ratio | 35.61 | 59.76 | 50.96 | 36.30 | 45.72 | 63.05 | Upgrade
|
| P/OCF Ratio | 48.05 | 56.56 | 46.33 | 34.75 | 42.22 | 43.01 | Upgrade
|
| PEG Ratio | 3.50 | 3.50 | 3.50 | 3.50 | 3.50 | 3.50 | Upgrade
|
| EV/Sales Ratio | 8.81 | 9.07 | 6.50 | 8.24 | 8.12 | 6.26 | Upgrade
|
| EV/EBITDA Ratio | 30.86 | 35.58 | 26.83 | 36.36 | 41.42 | 31.37 | Upgrade
|
| EV/EBIT Ratio | 32.72 | 37.35 | 28.26 | 38.65 | 45.71 | 34.36 | Upgrade
|
| EV/FCF Ratio | 33.38 | 56.89 | 48.05 | 34.80 | 44.50 | 60.28 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | 0.01 | 0.02 | 0.02 | 0.03 | 0.06 | 0.06 | Upgrade
|
| Debt / FCF Ratio | 0.02 | 0.03 | 0.04 | 0.03 | 0.06 | 0.13 | Upgrade
|
| Asset Turnover | 1.01 | 1.00 | 0.82 | 0.85 | 0.94 | 0.92 | Upgrade
|
| Inventory Turnover | 2.62 | 2.75 | 2.62 | 2.55 | 2.49 | 2.73 | Upgrade
|
| Quick Ratio | 1.31 | 1.45 | 1.50 | 1.83 | 1.02 | 1.17 | Upgrade
|
| Current Ratio | 1.66 | 1.84 | 1.88 | 2.18 | 1.63 | 1.74 | Upgrade
|
| Return on Equity (ROE) | 42.03% | 33.53% | 27.59% | 18.39% | 17.42% | 4.71% | Upgrade
|
| Return on Assets (ROA) | 17.09% | 15.24% | 11.75% | 11.27% | 10.40% | 10.41% | Upgrade
|
| Return on Capital (ROIC) | 36.91% | 29.52% | 21.07% | 20.82% | 19.24% | 18.33% | Upgrade
|
| Return on Capital Employed (ROCE) | 49.62% | 41.30% | 37.42% | 23.81% | 29.52% | 27.80% | Upgrade
|
| Earnings Yield | 2.02% | 1.79% | 2.72% | 6.02% | 1.47% | 0.44% | Upgrade
|
| FCF Yield | 2.81% | 1.67% | 1.96% | 2.75% | 2.19% | 1.59% | Upgrade
|
| Dividend Yield | 1.62% | 1.68% | 2.51% | 1.99% | 2.35% | 1.86% | Upgrade
|
| Payout Ratio | 80.23% | 91.80% | 249.80% | 29.89% | 189.04% | 363.51% | Upgrade
|
| Total Shareholder Return | 3.51% | 1.68% | 2.51% | 1.99% | 2.35% | 1.86% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.